Novel patient‐derived xenograft and cell line models for therapeutic screening in <scp>NF2</scp> ‐associated schwannoma-Reference-Cited by-同舟云学术

Novel patient‐derived xenograft and cell line models for therapeutic screening in NF2 ‐associated schwannoma

Published:2022-04-28 Issue:5 Volume:257 Page:620-634
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Zhao Fu¹²^ORCID,Chen Yang³,Li Shi‐Wei¹²,Zhang Jing¹,Zhang Shun¹,Zhao Xiao‐Bin⁴,Yang Zhi‐Jun¹²,Wang Bo²,He Qi‐Yang³,Wang Lei‐Ming⁵,Xu Lei⁶,Liu Pi‐Nan¹²

Affiliation:

1. Department of Neural Reconstruction, Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute Capital Medical University Beijing PR China

2. Department of Neurosurgery, Beijing Tiantan Hospital Capital Medical University Beijing PR China

3. Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences Beijing PR China

4. Department of Nuclear Medicine, Beijing Tian Tan Hospital Capital Medical University Beijing PR China

5. Departments of Pathology, Xuanwu Hospital Capital Medical University Beijing PR China

6. Department of Radiation Oncology Massachusetts General Hospital and Harvard Medical School Boston MA USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5908

Reference43 articles.

1. Neurofibromatosis type 2

2. Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based Study

3. STEREOTACTIC RADIOSURGERY FOR VESTIBULAR SCHWANNOMAS IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2

4. Emerging therapeutic targets in schwannomas and other merlin-deficient tumors

5. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions;Oncology and Therapy;2024-05-17

2. Diagnostic potential of NRG1 in benign nerve sheath tumors and its influence on the PI3K-Akt signaling and tumor immunity;Diagnostic Pathology;2024-02-08

3. The genetic landscape and possible therapeutics of neurofibromatosis type 2;Cancer Cell International;2023-05-23

4. Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma;Drugs of the Future;2023-03

5. Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma;Frontiers in Pharmacology;2022-08-19